UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Tapin-2525-Plaster-SE-AJ-RA

Generated Narrative: RegulatedAuthorization Tapin-2525-Plaster-SE-AJ-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/49407

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00049407,http://ema.europa.eu/fhir/eurdId#1867; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Medicated plaster; indication = Lidokain/prilokain plåster används vid: Ytanestesi av intakt hud i samband med: nålstick, t.ex. intravenösa katetrar eller blodprovstagning ytliga kirurgiska ingrepp, hos vuxna och den pediatriska populationen.; legalStatusOfSupply = Medicinal product subject to medical prescription exempt for some pack sizes; classification = combinations

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2014-07-24

holder: Organization Orifarm Generics A/S

Cases

-TypeDate[x]
*First Authorisation2014-07-24